If you are a junior doctor working out which specialty to commit to, you are choosing in a harder market than the one your seniors trained into. Training numbers are scarce, competition ratios have climbed, and a growing number of doctors are reaching the Specialist Register through the Portfolio Pathway. The question underneath "which specialty" has quietly become "which specialty can I realistically reach consultant level in". So it is worth asking early: if I end up on the Portfolio Pathway in this specialty, what are my chances, and how hard will the evidence be to build?
That question has two halves, and most people only weigh one:
- Your specialty's approval rate, which you can read from the GMC's published quarterly data.
- Whether you can build the evidence where you work: how easily your job gives you the cases, the procedure numbers, the assessments and the sign-offs. This has far more to do with your post and department than with the specialty itself.
A specialty with a decent approval rate can still be brutal to evidence if your particular job does not give you the cases or the supervision. Weigh both.
It also helps to keep the scale in view. Completing a training programme remains by far the main route to the Specialist Register: in 2025 the GMC awarded 9,502 CCTs through training against roughly 750 Portfolio Pathway grants, more than ten times as many. The Portfolio Pathway is the smaller route, but it is growing, and for doctors who cannot secure a training number it is increasingly the realistic way to reach consultant level.
Factor one - Your specialty's published odds
The GMC publishes Portfolio Pathway outcomes by specialty every quarter. Two things stand out.
Don't read the overall figure as your own odds. Across all specialties in 2025, roughly six in ten applications succeeded. It is tempting to read that as a six-in-ten personal chance. But it blends dozens of specialties with very different realities and tells you almost nothing about yours. Treat it as a prompt to go and read your own specialty, not as a probability that applies to you.
The spread between specialties is wide, and the numbers per specialty are small. These are real figures from the GMC's 2025 quarterly data, chosen to show the range. The pass rate column is the span from the specialty's weakest quarter to its strongest across 2025, and the applications column is how many completed all year, which is what makes the rate swing.
| Specialty | 2025 pass rate, low to high quarter | Applications, 2025 | What it shows |
|---|---|---|---|
| Clinical radiology | 82 to 86% | ~105 | Consistently high, on real volume |
| Histopathology | 77 to 92% | ~40 | Consistently high |
| Ophthalmology | 57 to 90% | ~40 | Strong overall, but swings hard quarter to quarter |
| Anaesthetics | 18 to 81% | ~106 | The same specialty, wildly different quarters |
| Emergency medicine | 35 to 61% | ~99 | Middle of the pack, and it moves |
| Obstetrics and gynaecology | 53 to 73% | ~61 | Mid-range |
| General internal medicine | 38 to 58% | ~65 | Mid to lower, and it slid across the year |
| Cardiology | 29 to 58% | ~63 | Lower and volatile |
| General surgery | 27 to 50% | ~67 | Consistently among the lower rates |
The volatility within specialties is worth noting: Anaesthetics passed 81% of applications in one quarter of 2025 and 18% in another, on a similar number of applications each time. When only a couple of dozen applications complete in a specialty across a year, a handful of outcomes moves the headline a long way, and a specialty that looks weak this quarter can look fine the next. So read the GMC's live data across several quarters for your own specialty rather than trusting a single figure quoted in an article, including this one.
See the GMC's Doctors' specialist applications and certificates data
Factor two - Whether your job lets you build the evidence
Here is what the approval rate cannot tell you, and what often matters more: whether you can realistically build the evidence at all in the jobs you can get.
This is not about one specialty being intrinsically harder to evidence than another. Every specialty offers plenty to draw on: cases and complex cases, audit and quality improvement, teaching and supervision, MDT work, CPD, research. The difficulty is rarely the specialty. It is the post. Outside a training programme, building evidence depends on the work coming your way and on someone senior being willing to observe, assess and sign it off. The Royal Colleges are explicit that evidence carries weight only when your own role in it is clear, primary operator rather than observer, primary reporter rather than counter-signer, and that doctors in supportive departments progress faster because supervisors understand what is needed and help get assessments signed.
Doctors who have done it are blunt about where it breaks down:
"CESR requires a lot of hoop jumping and it's genuinely challenging to do it without good support in your local area."
— u/delpigeon, r/doctorsUK, February 2026
"Portfolio pathway is possible, but it requires a lot of legwork from yourself and honestly, luck in finding departments that will support you through it."
— u/ceih, r/doctorsUK, February 2026
Others describe non-training posts where the promise of portfolio "opportunity" is dangled as bait while the case mix and sign-off never materialise.
So when you weigh your options, ask the practical questions the table hides:
- Case access. In a non-training role in this specialty, will you actually see the case mix you need, and get your hands on the procedures rather than watching them?
- Sign-off culture. Will consultants here observe and sign you off, or will you have to fight for every form?
Whichever way those two questions fall, what actually counts as evidence for both is set out in your specialty specific guidance (SSG), published on the GMC website for every specialty on the Specialist Register. Read it early, before you commit, and make it your best friend: it tells you exactly what evidence your specialty needs. Check the specialty specific guidance for your specialty on the GMC site
Two doctors in the same specialty can have completely different experiences of this route depending on the answers, and that is not about the specialty. It is about where you land.
Where you work - the Trust matters as much as the department
Your job is as much about where you are as what you do, and different hospital Trusts have very different reputations for supporting the Portfolio Pathway. Some build evidence-gathering into non-training jobs, give you access to the cases, and have consultants used to signing portfolio competencies. Others leave you to it. The gap between those two environments can outweigh the gap between two specialties.
So if you are making applications and have any geographic flexibility, it is worth finding out whether the Trust you are applying to is known for supporting Portfolio applicants, with the mentorship and sign-off culture that makes the difference. It is a fair question to ask at interview, and a legitimate reason to target one Trust over another.
Where Alessia fits, whatever you choose
Whichever specialty you commit to, the underlying work is the same: capturing your clinical experience as evidence, mapped to what your specialty requires, kept organised across years and jobs so it is ready when you are. That is why we built Alessia. You log as you go, tag entries to the competencies and curriculum areas they evidence, and keep a portfolio that travels with you between posts and Trusts instead of being rebuilt from scratch each time you move.
And the part this article keeps returning to, getting a consultant to sign things off, is the part we are building for directly. We are building automated supervisor sign-off loops into Alessia to ease the exact barrier the doctors above describe, so that bottleneck traps fewer doctors. That sits on our roadmap, and we are building it because we want doctors to succeed on this route whatever specialty they choose. Less admin, more medicine, from the year you decide onward.
The short version
A few questions to weigh a specialty by:
- What is your specialty's approval trend across the last few quarters of GMC data, not a single snapshot?
- What does your specialty's specialty specific guidance ask for, and how heavy is that ask?
- In a non-training post, will you get the case access and procedure numbers you need?
- Will consultants in your department observe and sign you off, or will you be fighting for every form?
- Does your hospital Trust support the Portfolio Pathway, and if not, could you target one that does?
There is no single Portfolio Pathway success rate that applies to you. There is your specialty's published trend, and there is whether you can build the evidence in the jobs you can get, which matters at least as much. Add a supportive Trust, start your evidence early, and the route stops being a gamble on a headline number and becomes something you can plan. Whatever you choose, build your evidence in a tool made for the long haul, like Alessia, so that years of clinical work hold together into one robust, reliable portfolio that is ready when you are.
Sources
- GMC, Portfolio Pathway (formerly CESR/CEGPR) granted, full-year 2025
- GMC, CCTs awarded 2025
- GMC, Specialty specific guidance for the Portfolio Pathway
- NHS England, 2025 specialty training competition ratios
- r/doctorsUK, "Career turmoil - UK non-training pathway or go back to India for residency? Need advice" (February 2026)
